Dr Reddy’s launches generic acid reflux drug in USA

July 18, 2016

Pharma giant Dr Reddy’s Laboratories have launched generic Omeprazole and Sodium bicarbonate capsules, used for treatment of acid reflux and ulcers, in the US market after receiving approval from the United States Food and Drug Administration (USFDA).

Dr Reddy’s Laboratories in a filing to the BSE has pointed that the company has launched the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg after the approval from the country’s health regulator USFDA. The company also added that capsules are the generic version of Santarus Inc’s Zegerid capsules.

Dr Reddy’s Laboratories said that according to IMS Health the Zegerid and generic brand had a sales of approximately $306.7 million in the US market, for 12 months ending in May 2016.